Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

David John Kuter, M.D., DR.PHIL.

TitleProfessor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Hem/Onc, Cox 640
100 Blossom Street
Boston MA 02114
Phone617/726-8743
Fax617/724-3166
Other Positions
TitleMember of the Affiliated Faculty of the Harvard-MIT Division of Health Sciences and Technology
InstitutionMassachusetts Institute of Technology
DepartmentHealth Sciences and Technology


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Egan TJ, Kuter D. Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter. Future Microbiol. 2013 Apr; 8:475-89.
    View in: PubMed
  2. Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol. 2013 May; 161(3):411-23.
    View in: PubMed
  3. Kuter D, Venter GA, Naidoo KJ, Egan TJ. Experimental and time-dependent density functional theory characterization of the UV-visible spectra of monomeric and µ-oxo dimeric ferriprotoporphyrin IX. Inorg Chem. 2012 Oct 1; 51(19):10233-50.
    View in: PubMed
  4. Schulman S, Awad MM, Kuter DJ. Neutrophil-erythrocyte rosettes in autoimmune hemolytic anemia. Am J Hematol. 2013 Apr; 88(4):333-4.
    View in: PubMed
  5. Colwell AS, Reish RG, Kuter DJ, Damjanovic B, Austen WG, Fogerty AE. Abdominal contouring procedures increase activity of the coagulation cascade. Ann Plast Surg. 2012 Aug; 69(2):129-33.
    View in: PubMed
  6. Kuter DJ, Mathias SD, Rummel M, Mandanas R, Giagounidis AA, Wang X, Deuson RR. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. Am J Hematol. 2012 May; 87(5):558-61.
    View in: PubMed
  7. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, Akeda Y, Matias RR, Kuter DJ, Nagata S, Natividad FF, Oishi K. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis. 2012 Apr 15; 205(8):1321-9.
    View in: PubMed
  8. Kuter DJ. What is the potential for thrombopoietic agents in acute leukemia? Best Pract Res Clin Haematol. 2011 Dec; 24(4):553-8.
    View in: PubMed
  9. Reddy P, Atay JK, Selbovitz LG, Connors JM, Piazza G, Block CC, Arpino PA, Berliner N, Hutter AM, Fischer MA, Kuter D, Weitzman J, Sherwood GK, Almozlino A, Giugliano RP. Dabigatran: a review of clinical and pharmacoeconomic evidence. Crit Pathw Cardiol. 2011 Sep; 10(3):117-27.
    View in: PubMed
  10. Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 1; 9(8):914-32.
    View in: PubMed
  11. Belmatoug N, Burlina A, Giraldo P, Hendriksz CJ, Kuter DJ, Mengel E, Pastores GM. Gastrointestinal disturbances and their management in miglustat-treated patients. J Inherit Metab Dis. 2011 Oct; 34(5):991-1001.
    View in: PubMed
  12. Kuter D, Chibale K, Egan TJ. Linear free energy relationships predict coordination and p-stacking interactions of small molecules with ferriprotoporphyrin IX. J Inorg Biochem. 2011 May; 105(5):684-92.
    View in: PubMed
  13. Dubar F, Egan TJ, Pradines B, Kuter D, Ncokazi KK, Forge D, Paul JF, Pierrot C, Kalamou H, Khalife J, Buisine E, Rogier C, Vezin H, Forfar I, Slomianny C, Trivelli X, Kapishnikov S, Leiserowitz L, Dive D, Biot C. The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance. ACS Chem Biol. 2011 Mar 18; 6(3):275-87.
    View in: PubMed
  14. Kuter DJ. Romiplostim. Cancer Treat Res. 2011; 157:267-88.
    View in: PubMed
  15. Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010 Dec; 8(12):2642-50.
    View in: PubMed
  16. Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 2010 Nov 11; 363(20):1889-99.
    View in: PubMed
  17. Lennerz JK, Kuter DJ, Hasserjian R, Iafrate J. Massive hepatomegaly and involvement by Janus Kinase 2-positive myeloproliferative neoplasm. Hepatology. 2010 Nov; 52(5):1855-6.
    View in: PubMed
  18. Davids MS, Murali MR, Kuter DJ. Serum free light chain analysis. Am J Hematol. 2010 Oct; 85(10):787-90.
    View in: PubMed
  19. Rabin DU, Kuter DJ, Liebman HA, Bussel JB. What do healthcare providers ask their patients with immune thrombocytopenia? Am J Hematol. 2010 Aug; 85(8):629-31.
    View in: PubMed
  20. Bussel JB, Kuter DJ. New thrombopoietic agents: introduction. Semin Hematol. 2010 Jul; 47(3):211.
    View in: PubMed
  21. Kuter DJ. Biology and chemistry of thrombopoietic agents. Semin Hematol. 2010 Jul; 47(3):243-8.
    View in: PubMed
  22. Fleischmann KH, Kuter DJ, Coley CM, Rathmell JP. Practice guidelines often fail to keep pace with the rapid evolution of medicine: a call for clinicians to remain vigilant and revisit their own practice patterns. Reg Anesth Pain Med. 2010 Jan-Feb; 35(1):4-7.
    View in: PubMed
  23. Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec; 23(6):1193-211.
    View in: PubMed
  24. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14; 115(2):168-86.
    View in: PubMed
  25. Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood. 2009 Oct 29; 114(18):3748-56.
    View in: PubMed
  26. Corrêa Soares JB, Menezes D, Vannier-Santos MA, Ferreira-Pereira A, Almeida GT, Venancio TM, Verjovski-Almeida S, Zishiri VK, Kuter D, Hunter R, Egan TJ, Oliveira MF. Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols. PLoS Negl Trop Dis. 2009; 3(7):e477.
    View in: PubMed
  27. Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan DE, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg HR, Schlossman RL, Munshi NC, Heffner LT, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol. 2009 Jul 20; 27(21):3518-25.
    View in: PubMed
  28. Davis AK, Makar RS, Stowell CP, Kuter DJ, Dzik WH. ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13. Transfusion. 2009 Feb; 49(2):206-13.
    View in: PubMed
  29. Kuter DJ. New thrombopoietic growth factors. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S347-56.
    View in: PubMed
  30. Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009; 60:193-206.
    View in: PubMed
  31. Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J, Freifeld AG, Goemann M, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, Michaud LB, Miyata SC, Tallman MS, Vadhan-Raj S, Westervelt P, Wong MK. Myeloid growth factors. J Natl Compr Canc Netw. 2009 Jan; 7(1):64-83.
    View in: PubMed
  32. Soupir CP, Vergilio JA, Kelly E, Dal Cin P, Kuter D, Hasserjian RP. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol. 2009 Mar; 144(5):800-2.
    View in: PubMed
  33. Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009 Mar 5; 113(10):2161-71.
    View in: PubMed
  34. McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R. Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008 Sep; 48(9):2008-25.
    View in: PubMed
  35. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 2; 371(9610):395-403.
    View in: PubMed
  36. Kuter DJ. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008 Feb; (69):9-18.
    View in: PubMed
  37. Kuter DJ. Meeting the treatment challenges of chronic immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008 Feb; (69):1-2.
    View in: PubMed
  38. Nugmanova A, Pillai G, Nugmanova D, Kuter D. Improving the management of hypertension in Kazakhstan: implications for improving clinical practice, patient behaviours and health outcomes. Glob Public Health. 2008; 3(2):214-31.
    View in: PubMed
  39. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol. 2007 Nov; 139(3):351-62.
    View in: PubMed
  40. Park JH, Spitzer T, Kuter DJ. Successful treatment of pure red cell aplasia with autologous stem cell transplantation. Am J Hematol. 2007 Sep; 82(9):812-4.
    View in: PubMed
  41. Moore A, Lau E, Yang C, Mackool B, Kuter DJ. Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma. Am J Clin Oncol. 2007 Jun; 30(3):329-31.
    View in: PubMed
  42. Kuter DJ. New thrombopoietic growth factors. Blood. 2007 Jun 1; 109(11):4607-16.
    View in: PubMed
  43. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.
    View in: PubMed
  44. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
    View in: PubMed
  45. Yee AJ, Kuter DJ. Successful recovery after an overdose of argatroban. Ann Pharmacother. 2006 Feb; 40(2):336-9.
    View in: PubMed
  46. Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc. 2005 Aug; 80(8):1022-8.
    View in: PubMed
  47. Kuter DJ. The promise of thrombopoietins in the treatment of ITP. Clin Adv Hematol Oncol. 2005 Jun; 3(6):464-6.
    View in: PubMed
  48. Mogues T, Li J, Coburn J, Kuter DJ. IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin. J Immunol Methods. 2005 May; 300(1-2):1-11.
    View in: PubMed
  49. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am. 2005 Feb; 19(1):183-202, vii.
    View in: PubMed
  50. Valeri CR, Ragno G, Marks PW, Kuter DJ, Rosenberg RD, Stossel TP. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days. Transfusion. 2004 Jun; 44(6):865-70.
    View in: PubMed
  51. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist. 2004; 9(2):207-16.
    View in: PubMed
  52. Nasraway SA, Shorr AF, Kuter DJ, O'Grady N, Le VH, Cammarata SK. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis. 2003 Dec 15; 37(12):1609-16.
    View in: PubMed
  53. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion. 2003 Jul; 43(7):857-66.
    View in: PubMed
  54. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003 Jun 26; 348(26):2609-17.
    View in: PubMed
  55. Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood. 2002 Nov 15; 100(10):3457-69.
    View in: PubMed
  56. Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, Kuter DJ. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002 Aug; 46(8):2723-6.
    View in: PubMed
  57. Kuter DJ. Apoptosis in platelets during ex vivo storage. Vox Sang. 2002 Aug; 83 Suppl 1:311-3.
    View in: PubMed
  58. Kakkar AK, Levine MN, Prandoni P, Lee AY, Rasmussen MS, Kuter D. What is the role for antithrombotics in cancer care? Interactive session with panel discussion. Cancer Treat Rev. 2002 Jun; 28(3):157-9.
    View in: PubMed
  59. Kuter DJ. Whatever happened to thrombopoietin? Transfusion. 2002 Mar; 42(3):279-83.
    View in: PubMed
  60. Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol. 2001 Dec; 74(4):365-74.
    View in: PubMed
  61. Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001 Dec 1; 98(12):3241-8.
    View in: PubMed
  62. Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood. 2001 Sep 1; 98(5):1346-51.
    View in: PubMed
  63. Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J. Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood. 2001 Sep 1; 98(5):1339-45.
    View in: PubMed
  64. Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy. 2001 Aug; 21(8):1010-3.
    View in: PubMed
  65. Brown JR, Kuter DJ. The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients. Thromb Haemost. 2001 Jun; 85(6):979-85.
    View in: PubMed
  66. Glaspy J, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Rigas J, Kuter D, Harmon D, Prow D, Demetri G, Gordon D, Arseneau J, Saven A, Hynes H, Boccia R, O'Byrne J, Colowick AB. A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer. 2001 Apr; 84 Suppl 1:17-23.
    View in: PubMed
  67. Allgood GS, Kuter DJ, Roll KT, Taylor SL, Zorich NL. Postmarketing surveillance of new food ingredients: results from the program with the fat replacer olestra. Regul Toxicol Pharmacol. 2001 Apr; 33(2):224-33.
    View in: PubMed
  68. Li J, Xia Y, Kuter DJ. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Br J Haematol. 2000 Dec; 111(3):943-53.
    View in: PubMed
  69. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion. 2000 Nov; 40(11):1320-9.
    View in: PubMed
  70. Xia Y, Li J, Bertino A, Kuter DJ. Thrombopoietin and the TPO receptorduring platelet storage. Transfusion. 2000 Aug; 40(8):976-87.
    View in: PubMed
  71. Li J, Sabath DF, Kuter DJ. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets. Cytokine. 2000 Jul; 12(7):835-44.
    View in: PubMed
  72. Kuter DJ. Future directions with platelet growth factors. Semin Hematol. 2000 Apr; 37(2 Suppl 4):41-9.
    View in: PubMed
  73. Snyder EL, Kuter DJ. Apoptosis in transfusion medicine: of death and dying--is that all there is? Transfusion. 2000 Feb; 40(2):135-8.
    View in: PubMed
  74. Li J, Xia Y, Kuter DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol. 1999 Aug; 106(2):345-56.
    View in: PubMed
  75. Yang C, Li YC, Kuter DJ. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat. Br J Haematol. 1999 May; 105(2):478-85.
    View in: PubMed
  76. Kuter DJ, Cebon J, Harker LA, Petz LD, McCullough J. Platelet growth factors: potential impact on transfusion medicine. Transfusion. 1999 Mar; 39(3):321-32.
    View in: PubMed
  77. Letai A, Kuter DJ. Cancer, coagulation, and anticoagulation. Oncologist. 1999; 4(6):443-9.
    View in: PubMed
  78. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998 Jul; 105(1):27-32.
    View in: PubMed
  79. Goodnough LT, Kuter D, McCullough J, Brecher ME. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose. J Clin Apher. 1998; 13(3):114-9.
    View in: PubMed
  80. Kuter DJ. Thrombopoietins and thrombopoiesis: a clinical perspective. Vox Sang. 1998; 74 Suppl 2:75-85.
    View in: PubMed
  81. Murphy J, Kuter DJ. Trombopoietin: from molecule to medicine. Preface. Stem Cells. 1998; 16 Suppl 2:xi-xii.
    View in: PubMed
  82. Kuter DJ. The use of PEG-rhuMGDF in platelet apheresis. Stem Cells. 1998; 16 Suppl 2:231-42.
    View in: PubMed
  83. Kuter DJ. Cover art: the watercolor drawings of James Homer Wright. Stem Cells. 1998; 16 Suppl 2:ix-x.
    View in: PubMed
  84. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest. 1997 Sep 1; 100(5):1193-8.
    View in: PubMed
  85. Sheridan WP, Kuter DJ. Mechanism of action and clinical trials of Mpl ligand. Curr Opin Hematol. 1997 Sep; 4(5):312-6.
    View in: PubMed
  86. Sirois MG, Simons M, Kuter DJ, Rosenberg RD, Edelman ER. Rat arterial wall retains myointimal hyperplastic potential long after arterial injury. Circulation. 1997 Aug 19; 96(4):1291-8.
    View in: PubMed
  87. Kuter DJ. In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands. Curr Opin Hematol. 1997 May; 4(3):163-70.
    View in: PubMed
  88. Kuter DJ. Thrombopoietin: biology, clinical applications, role in the donor setting. J Clin Apher. 1996; 11(3):149-59.
    View in: PubMed
  89. Kuter DJ. The physiology of platelet production. Stem Cells. 1996; 14 Suppl 1:88-101.
    View in: PubMed
  90. Kuter DJ. Thrombopoietin: Biology and Clinical Applications. Oncologist. 1996; 1(1 & 2):98-106.
    View in: PubMed
  91. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood. 1995 May 15; 85(10):2720-30.
    View in: PubMed
  92. Ravid K, Kuter DJ, Rosenberg RD. rmIL-6 stimulates the transcriptional activity of the rat PF4 gene. Exp Hematol. 1995 May; 23(5):397-401.
    View in: PubMed
  93. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994 Nov 8; 91(23):11104-8.
    View in: PubMed
  94. Kuter DJ, Rosenberg RD. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood. 1994 Sep 1; 84(5):1464-72.
    View in: PubMed
  95. Ravid K, Kuter DJ, Beeler DL, Doi T, Rosenberg RD. Selection of an HEL-derived cell line expressing high levels of platelet factor 4. Blood. 1993 Jun 1; 81(11):2885-90.
    View in: PubMed
  96. Kuter DJ, Gminski D, Rosenberg RD. Botrocetin agglutination of rat megakaryocytes: a rapid method for megakaryocyte isolation. Exp Hematol. 1992 Oct; 20(9):1085-9.
    View in: PubMed
  97. Kuter DJ, Gminski DM, Rosenberg RD. Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood. 1992 Feb 1; 79(3):619-26.
    View in: PubMed
  98. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol. 1991 Dec; 11(12):6116-27.
    View in: PubMed
  99. Kuter DJ, Gminski D, Rosenberg RD. Platelets contain several inhibitors of megakaryocyte growth and ploidization. Prog Clin Biol Res. 1990; 356:245-57.
    View in: PubMed
  100. Kuter DJ, Rosenberg RD. Regulation of megakaryocyte ploidy in vivo in the rat. Blood. 1990 Jan 1; 75(1):74-81.
    View in: PubMed
  101. Kuter DJ, Greenberg SM, Rosenberg RD. Analysis of megakaryocyte ploidy in rat bone marrow cultures. Blood. 1989 Nov 1; 74(6):1952-62.
    View in: PubMed
  102. Bell DF, Harris WH, Kuter DJ, Wessinger SJ. Elevated partial thromboplastin time as an indicator of hemorrhagic risk in postoperative patients on warfarin prophylaxis. J Arthroplasty. 1988; 3(2):181-4.
    View in: PubMed
  103. Greenberg SM, Kuter DJ, Rosenberg RD. In vitro stimulation of megakaryocyte maturation by megakaryocyte stimulatory factor. J Biol Chem. 1987 Mar 5; 262(7):3269-77.
    View in: PubMed
  104. Kuter DJ, Rodgers A. The protein composition of HeLa ribosomal subunits and nucleolar precursor particles. Exp Cell Res. 1976 Oct 1; 102(1):205-12.
    View in: PubMed
  105. Kuter DJ, Rodgers A. Ribosomal protein differences between animal cells. Exp Cell Res. 1974 Jul; 87(1):186-94.
    View in: PubMed
  106. Weber K, Kuter DJ. Reversible denaturation of enzymes by sodium dodecyl sulfate. J Biol Chem. 1971 Jul 25; 246(14):4504-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Kuter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (501) concept(s)
_
Co-Authors
See all (54) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_